Strattera (atomoxetine)
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
ADHD NOS
Conditions
ADHD NOS
Trial Timeline
Dec 1, 2003 โ Jul 1, 2008
NCT ID
NCT00181766About Strattera (atomoxetine)
Strattera (atomoxetine) is a approved stage product being developed by Eli Lilly for ADHD NOS. The current trial status is completed. This product is registered under clinical trial identifier NCT00181766. Target conditions include ADHD NOS.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00181766 | Approved | Completed |
Competing Products
20 competing products in ADHD NOS